FrontPage is India's Stock Market Social Network
Join 3,00,000+ Traders and Investors
PFIZER
40123456789,501234567895012345678900123456789.3012345678950123456789
-49.05 (-1.07%)
Previous Close: 4599.4
1D
5D
1M
3M
1Y
5Y
Popular Posts

Srksagar

https://economictimes.indiatimes.com/news/international/world-news/china-weighs-exit-from-zero-covid-and-the-risks-involved/articleshow/90304363.cms #PFIZER

NewsBot

The Delta Trader

https://economictimes.indiatimes.com/news/international/world-news/britain-approves-pfizers-antiviral-covid-19-pill/articleshow/88616600.cms #PFIZER

NewsBot

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-nod-in-hand-pfizer-is-looking-for-partners-to-make-covid-drug-in-india/articleshow/88442898.cms #PFIZER

NewsBot

https://economictimes.indiatimes.com/news/india/experts-divided-over-new-study-claiming-omicron-may-evade-vaccination/articleshow/88175937.cms #PFIZER

NewsBot

*Futures & Options educational trades for the week 22.11.21 to 26.11.21* (My trade guidelines -appended below - apply). #stockmarket *FUTURES* #PFIZER *PFIZER* cmp 5085.00 buy upto 4950.00 stop 4870.00 target 5380.00+

Sridhar Balakrishnan

https://economictimes.indiatimes.com/news/international/world-news/us-expands-covid-19-booster-shots-to-all-adults-final-hurdle-ahead/articleshow/87803043.cms #PFIZER

NewsBot

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-enters-deal-with-un-backed-mpp-to-license-covid-drug-in-95-countries-including-india/articleshow/87741444.cms #PFIZER

NewsBot

ICICIdirect.com target on PFIZER Date: 09-Nov-21 Broker: ICICIdirect.com Price @ Call: 5160 Target: 6020 Potential: 16.67% Recommendation: BUY

ReportBot

POSSIBLE BULLISH STOCKS for coming days This view is based on volume data, oi data, delivery data & price action posts are for educational purposes only & not any recommendation #HINDPETRO #IGL #MUTHOOTFIN #PFIZER

vijay jaria

#IRCTC #PFIZER #INDUSTOWER 💥💥💥 watch out #FEDERALBNK Today paid call 👇🏼👇🏼👇🏼

Elavarasan

A

aaaaa

Major Earnings Today: #BATAINDIA #SBIN #EICHERMOT #ABFRL #PFIZER Gujarat State Petronet Uflex Grindwell Norton Gujarat Alkalies & Chemicals

Revanth Nifty Radar

Portfolio Buddy

https://economictimes.indiatimes.com/news/international/world-news/uk-advisers-decide-against-covid-vaccines-for-healthy-12-to-15-year-olds/articleshow/85904813.cms #PFIZER

NewsBot

Shopping List of Stocks that were good to Buy today onwards : PFIZER VOLTAS MARICO PIDILITE IND BEL #NIFTY50 #BEL #VOLTAS #PFIZER #MARICO

Akshay

Akshay

KrisDom Investor

KrisDom Investor

Crossed 5500.... #NIFTY50 #PFIZER

Akshay

Crossed 5400.... #NIFTY50 #PFIZER

Akshay

Akshay

#PFIZER USFDA approved vaccine for 12-15 years old kids!!

ProTip Price Action

#JUBLFOOD #HDFCBANK #BIOCON #MARICO #PFIZER

Nifty Profit Makers

Akshay

Akshay

TradingEdge Academy

BankNifty Expert

https://economictimes.indiatimes.com/news/international/world-news/moderna-covid-19-vaccine-begins-rollout-as-u-s-races-to-broaden-injection-campaign/articleshow/79821017.cms #PFIZER

NewsBot

BankNifty Expert

https://economictimes.indiatimes.com/news/international/world-news/pfizer-says-not-facing-production-issues-with-covid-19-vaccine/articleshow/79784220.cms #PFIZER

NewsBot

https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/dhl-global-forwarding-transports-russias-sputnik-v-vaccine-into-india-for-clinical-trials/articleshow/79266472.cms #PFIZER

NewsBot

https://economictimes.indiatimes.com/news/international/world-news/in-covid-19-vaccine-race-hungarian-village-firm-takes-global-role/articleshow/79232660.cms #PFIZER

NewsBot

https://economictimes.indiatimes.com/markets/commodities/news/opec-gets-scant-relief-from-vaccine-as-it-meets-to-discuss-cuts/articleshow/79229114.cms #OIL #PFIZER

NewsBot

Pfizer’s Covid Vaccine Prevents 90% of Infections in Study · The Covid-19 vaccine being developed by Pfizer Inc. and BioNTech SE prevented more than 90% of infections in a study of tens of thousands of volunteers, the most encouraging scientific advance so far in the battle against the coronavirus. Eight months into the worst pandemic in a century, the preliminary results pave the way for the companies to seek an emergency-use authorization from regulators if further research shows the shot is also safe. · Pfizer shares extended gains in premarket trading, rising about 16%, with BioNTech American depositary receipts up about 27%. The news added more than $500 billion to the value of the MSCI All Country World Index. Encouraging Vaccine Results Could Mean There’s a Tool to Control Virus. #PFIZER

Alpha Signals

Alpha Signals

Results on November 2 HDFC, Cadila Healthcare, Punjab National Bank, NTPC, Bandhan Bank, AIA Engineering, Anant Raj, BF Utilities, Coromandel International, City Union Bank, Embassy Office Parks REIT, Escorts, Narayana Hrudayalaya, OnMobile Global, Pfizer, PNC Infratech, Shriram City Union Finance, TCI Express, Whirlpool of India, Wockhardt, Wonderla Holidays and Zee Entertainment Enterprises among 61 companies will declare their quarterly earnings on November 2. #NIFTY50 #HDFC #ESCORTS #PFIZER

Alpha Signals

#PFIZER Pharmaceutical giant Pfizer has said it would seek emergency use authorisation for its coronavirus vaccine from the US Food and Drug Administration, once it was established that the vaccine was indeed effective. The company said this could happen as early as the end of next month, and it intended to apply for emergency license immediately after that, according to a report in The New York Times. Pfizer’s vaccine, being developed in collaboration with German partner BioNTech, is currently undergoing third and last stage of clinical trials. Its chief executive Albert Bourla said about 23,000 volunteers had been enrolled for the stage-3 trials, and many of them had been administered the second booster dose as well. He said the company would know “in October time frame” how effective the vaccine had been on the volunteers. He said if the effectiveness data was good, the company would immediately apply for emergency use authorisation

Sridhar Balakrishnan

Bullish for next few days PFIZER BUY ABOVE 4127 Target 4150/4160/4170 SL 4115 Astrazen BUY ABOVE 3341 Target 3360/3370/3380 SL 3330 ITI BUY ABOVE 132 Target 137/139/140 #PFIZER #ITI #ASTRAZEN

Pavan Sikchi

#PFIZER Pfizer stock jumps after reporting positive early coronavirus vaccine trial data https://www.cnbc.com/2020/07/01/pfizer-stock-jumps-after-it-reports-positive-data-in-early-stage-coronavirus-vaccine-trial.html?__source=androidappshare

Sridhar Balakrishnan

PFIZER SAYS CONFIDENT TO DELIVER MILLION DOSES OF COVID19 DRUG BY SEPTEMBER Bhagwan bhacha ke rakhna september tak 🤣 #PFIZER

King999

Good news Pfizer, BioNTech Covid Vaccine Cleared for Human Tests - Bloomberg https://apple.news/ASXlLpExwRzicfESeOGlspQ #PFIZER

Sridhar Balakrishnan

NewsBot-display-image
Reputation: 27,802  •  Yesterday 5:51 AM
Buy Pfizer, target price Rs 5250: Anand Rathi
Pfizer, incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20966.41 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Nov 21 4:23 AM
Hold Pfizer; target of Rs 4505: ICICI Direct
ICICI Direct recommended hold rating on Pfizer with a target price of Rs 4505 in its research report dated November 17, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Nov 18 3:46 AM
Hold Pfizer, target price Rs 4505: ICICI Direct
Pfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20569.10 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Oct 22 2:51 AM
Stocks end higher on Wall Street, notching weekly gains
The Fed is expected to raise interest rates another three-quarters of a percentage point at its upcoming meeting in November. Markets have been unsettled partly because investors have been hoping that any sign of inflation easing or economic growth slowing could signal that the Fed will ease up on its rate increases, which have yet to show any signs of significantly impacting inflation.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Oct 11 12:03 PM
Hot Stocks | RPG Life, Krishna Institute of Medical Sciences, Pfizer can give healthy returns in short term. Here's why
Indicators and oscillators like MACD (moving average convergence and divergence) and RSI have turned bullish on the weekly charts. KIMS is placed above all important moving averages, indicating bullish trend on all time frames.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Oct 6 3:26 AM
Stocks to buy or sell: 8 short-term trading ideas by experts for 6 October 2022
And whenever there is a rally in US markets, India is outperforming reflecting the resilience of Indian economy and markets. Investors should not be carried away by the rallies because there are major challenges for the global economy and markets.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Oct 6 2:11 AM
Buy Pfizer, target price Rs 4725: HDFC Securities
Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Scrap for the year ending 31-Mar-2022.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Oct 3 5:16 AM
Hold Pfizer, target price Rs 4480: ICICI Direct
Pfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 19287.47 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Sep 12 12:48 PM
Hot Stocks | Here's why you should bet on ONGC, Gujarat Gas, Pfizer for short term
Recently on a weekly scale, Gujarat Gas confirmed a bullish Inverted Hammer candlestick pattern followed by a bullish Piercing pattern exactly at the mentioned support levels and that is adding more confirmation of further upside in the counter.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Sep 3 11:21 AM
UK approves Pfizer bivalent Covid vaccine ahead of booster drive
The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved the Pfizer jab as a booster for those aged 12 and over after a "careful review of the evidence". The UK regulator last month okayed a similar bivalent vaccine by Moderna, becoming the first country to do so. MHRA chief executive June Raine said: "I am pleased to announce that we now have a second approved vaccine for the UK Autumn booster programme."
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Sep 2 2:36 AM
'Completely new' Covid strains possible this winter: EU
It will include a mix of newly-approved jabs adapted for the now dominant Omicron strain, and the original vaccines developed to fight the virus that first emerged in China in 2019, the European Medicines Agency (EMA) said. But people "should not wait for a specific vaccine", EMA vaccines chief Marco Cavaleri told a news conference.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Sep 2 5:46 AM
Biological E's Pneumonia jab for kids gets nod
​​Streptococcus pneumoniae infection is a leading cause of child mortality under 5 years of age in India and other developing countries.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Sep 1 11:21 AM
BE's pediatric pneumonia jab gets CDSCO expert panel approval
The BE's pneumococcal conjugate vaccine (PCV) can be administered to infants at 6, 10 and 14 weeks of age. Streptococcus pneumoniae infection continues to be a leading cause of child mortality under 5 years of age in India and in developing countries.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Sep 1 8:36 AM
Dr Anthony Fauci sounds alarm bells for 'bad flu season' as he nears office exit. Read more for details
Chief Medical Advisor to the President of United States Dr Anthony Fauci advises people to get shots for Covid and flu ASAP. He also plans to encourage HIV shots. While alarming citizens, he asks the US to pay heed to the warning signs.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 27 8:26 AM
US first lady Jill Biden tests positive for COVID-19. Check out the details
The first lady of United States, Jill Biden, has tested positive for COVID-19 again, the White House said on Wednesday.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 26 1:01 AM
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine
Moderna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before COVID-19 emerged in 2019 and exploded into global consciousness in early 2020. Moderna has also been sued for patent infringement in the United States and has an ongoing dispute with the U.S. National Institutes of Health over rights to mRNA technology.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 26 3:41 AM
Countries with lower income faced 'systemic racism' in global Covid response: Report
A combination of undersupply of vaccines and treatments, underfunding of health systems, undervaluing of health workers, and poor adaptation to local needs were the key drivers behind low vaccination rates, informed researchers studying communities in 14 low and middle-income countries and territories.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 25 5:16 AM
Indian vaccine makers gaining wider market share in industry
According to a TOI report, indigenously-manufactured vaccines have started to capture share from MNCs in certain diseases even as the Rs 3,000 crore private market plummeted sharply by 15% in June month-on-month, one of the sharpest such declines in recent years.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 24 2:31 AM
WHO: COVID deaths down by 15%, cases fall nearly everywhere
In its latest weekly assessment of the COVID-19 pandemic, the U.N. health agency said there were 5.3 million new cases and more than 14,000 deaths reported last week. WHO said the number of new infections declined in every world region except the Western Pacific.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 23 3:16 AM
AstraZeneca may not stay in vaccines, but CEO has no COVID regrets
Soriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures - in October 2012, following a stint at pharma peer Roche. With the Frenchman at the helm, the fortunes of the Anglo-Swedish drugmaker changed dramatically.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 23 1:01 AM
AstraZeneca on hunt for acquisitions, says CEO Pascal Soriot
Soriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures - in October 2012, following a stint at pharma peer Roche.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 23 10:01 AM
Pfizer-BioNTech COVID shot 73.2% effective in kids under 5
Pfizer and BioNTech's vaccine was authorized for children under 5 years of age in June, based on data that showed the vaccine generated a similar immune response to those seen in older age groups. An early analysis based on 10 symptomatic COVID-19 cases in the study had suggested a vaccine efficacy of 80.3% in this group.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 23 10:11 AM
Novavax's protein-based jab offers better immunity against new variants: CEO Stanley Erck
Novavax's protein-based vaccine was approved for emergency use by the US Food and Drug Administration (USFDA) last month in India.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 17 7:31 AM
Sanofi trial failure ends development of breast cancer treatment amcenestrant
A trial dubbed AMEERA-5, which was testing amcenestrant on women with newly-diagnosed advanced breast cancer, was stopped early because an independent monitoring panel found no signs of it working. "All other studies of amcenestrant, including in early-stage breast cancer (AMEERA-6), will be discontinued," Sanofi said.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 15 11:21 AM
Pfizer CEO Albert Bourla tests positive for Covid, says has very mild symptoms
Pfizer Inc Chief Executive Officer Albert Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions. Paxlovid is an antiviral medication that is used to treat high-risk patients, such as older people.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 12 5:01 AM
Innovation in focus: How India can become a global R&D powerhouse
Make in India can be made better by shifting focus to employment in more labour-intensive industries, increasing India's global trade competitiveness and by GoI fully embracing an ancillary 'Innovate in India' campaign focused on facilitating India's rise as a global R&D hub and generating employment for high-skill workers.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 10 6:21 AM
Drug firm Pfizer's Managing Director S Sridhar resigns
He will continue to serve in his current position until the identification, selection and transition to the new leadership takes place in the company, it added.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 9 1:31 AM
Lyme disease vaccine: Major test underway. All you need to know
After twenty years, there is a possibility that a vaccine against Lyme disease will be ready. People are being tested for its efficacy in both Europe and the USA.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 8 3:33 AM
Hold Pfizer; target of Rs 4480: ICICI Direct
ICICI Direct recommended hold rating on Pfizer with a target price of Rs 4480 in its research report dated August 06, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Aug 5 11:06 AM
Pfizer Q1 Results: Profit falls 83% to Rs 33 crore
Revenue from operations declined to Rs 593 crore in the quarter from Rs 749 crore in the year-ago period.The drug firm said exceptional items for June quarter comprised Rs 130 crore on account of a voluntary retirement scheme and Rs 6 crore for restructuring to drive business transformation.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jul 29 12:26 PM
US reaches deal with Moderna for omicron Covid 19 vaccine
The order of the bivalent shot follows the announcement last month that the federal government had secured 105 million doses of a similar vaccine from rival drugmaker Pfizer. Both orders are scheduled for delivery in the fall and winter, assuming regulators sign off on their effectiveness. The Pentagon said the Moderna contract was worth $1.74 billion.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jul 29 6:21 AM
Zenara Gets Nod to Manufacture, Sell Pfizer's Paxlovid
​​The company said Nirmatrelvir and Ritonavir tablets will soon be available in a combi-pack, sold under the brand name Paxzen, as a treatment option for patients with mild to moderate symptoms of Covid-19. While the price of medicine is yet to be decided, it will be manufactured at Zenara's USFDA-approved state-of-the-art facility in Hyderabad.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jul 28 11:36 AM
Zenara Pharma gets CDSCO nod to launch Covid antiviral Paxlovid in India
The approval by the Central Drugs Standard Control Organization (CDSCO) has been granted under the emergency authorization route considering the unmet medical need.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jul 28 7:56 AM
Zenara pharma to launch generic Paxlovid soon
The company said that Nirmatrelvir and Ritonavir tablets in a combi pack as a treatment option for patients with mild to moderate symptoms of Covid-19 will be available soon.
The Economic Times
Like
Comment
Share
Add a comment
Sid-display-image
Reputation: 6,671  •  Jul 27 3:52 AM

Pfizer, BioNTech start mid-phase trial for Omicron vaccine
American Pfizer Inc. and its German partner BioNTech SE announced on Wednesday that they initiated a "randomized, active-controlled, observer-blind" mid-stage vaccine trial for an unspecified Omicron variant of COVID-19.
......read more
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jul 21 1:41 AM
US President Biden tests positive for COVID-19, has 'mild symptoms'
White House Press Secretary Karine Jean-Pierre said that Biden was experiencing "mild symptoms" and has begun taking Paxlovid, an antiviral drug designed to reduce the severity of the disease.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jul 21 9:11 AM
AstraZeneca, Pfizer COVID-19 vaccines offer high protection 6 months after second dose: Study
The researchers used records on 1,951,866 (19.5 lakh) and 3,219,349 (32 lakh) adults who had received two doses of Pfizer and AstraZeneca vaccnes, respectively and 2,422,980 (24 lakh) unvaccinated adults.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jul 13 12:36 PM
Experts believe Covid can get you again in 28 days. Social distancing & wearing a mask continue remain effective tools
Experts have reduced the protective window of prior infection from 12 weeks to 28 days.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jul 13 6:26 AM
Covid vaccines not linked to 'sudden adult death syndrome', say scientists
"There appears to be no evidence whatsoever so far linking COVID-19 vaccines and such deaths," immunologist Satyajit Rath from Pune's Indian Institute of Science Education and Research (IISER) said. The SADS Foundation in the US also issued a statement and said it recommends that SADS patients receive the COVID-19 shot.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jun 30 1:56 AM
Scientists reveal why even vaccinated people are prone to Covid-19 reinfections
Emerging research suggests that could put them at higher risk for health problems.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jun 29 2:01 AM
BioNTech, Pfizer to start testing universal vaccine for coronaviruses
Their experimental work on shots that go beyond the current approach include T-cell-enhancing shots, designed to primarily protect against severe disease if the virus becomes more dangerous, and pan-coronavirus shots that protect against the broader family of viruses and its mutations.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jun 28 10:31 AM
Panel recommends emergency use nod to India's 1st mRNA vaccine
The SEC recommended the authorisation in a meeting held on Friday. The vaccine is developed by Pune-based Gennova Biopharmaceuticals.
The Economic Times
Like
Comment
Share
Add a comment
vijay jaria-display-image
Reputation: 29,341  •  Jun 27 4:19 AM
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jun 24 2:06 AM
U.S. CDC backs Moderna's COVID vaccine for teens, older children
"Vaccinating this age group can provide greater confidence to families that their children and adolescents participating in childcare, school, and other activities will have less risk for serious COVID-19 illness," CDC Director Rochelle Walensky said in a statement on Friday.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jun 20 2:11 AM
Children in the age group of 1-4 in America are now eligible for Covid-19 vaccines
Children in the United States can now take the vaccine against the Covid-19. While a lot of parents are still undecided, some parents are confused. Many questions are floating around about the vaccine dose, and we have answered some of those.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jun 20 5:26 AM
Pfizer to buy 8.1% stake in French vaccines company Valneva
Valneva will use the proceeds from Pfizer's equity investment to support its Phase 3 development contribution to the Lyme disease program. Valneva and Pfizer also updated the terms of their collaboration and license agreement which they announced on April 30, 2020 for the Lyme disease vaccine candidate VLA15.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jun 19 5:31 AM
CDC advisers recommend Covid 19 shots for children under 5
The government has been gearing up for the start of the shots early next week, with millions of doses ordered for distribution to doctors, hospitals and community health clinics around the country. Roughly 18 million kids will be eligible, but it remains to be seen how many will ultimately get the vaccines. Less than a third of children ages 5 to 11 have done so since vaccination opened up to them last November.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jun 17 12:51 PM
FDA authorizes 1st COVID-19 shots for infants, preschoolers
The Food and Drug Administration's action follows its advisory panel's unanimous recommendation for the shots from Moderna and Pfizer. That means U.S. kids under 5 — roughly 18 million youngsters — are eligible for the shots, about 1 1/2 years after the vaccines first became available in the U.S. for adults, who have been hit the hardest during the pandemic.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,802  •  Jun 15 12:31 PM
U.S. FDA reviews Pfizer & Moderna Covid 19 vaccines in young children
US health experts' panel will be reviewing the use of covid vaccines in young children on Wednesday. If the committee recommends using covid vaccines, children between six months and five years may get vaccinated in the US.
The Economic Times
Like
Comment
Share
Add a comment